Pfizer reportedly is in talks to buy Wockhardt's biotech unit
Pfizer will proceed with its planned takeover of the biotech operations of Wockhardt even though the Indian drugmaker has not shown interest in a sale, a person familiar with the potential deal said. A second round of due diligence could lead to a buyout or strategic alliance, the source said. Neither of the companies commented on the prospect of acquisition talks.
Economic Times (India), The | 10/29
This story published in BIO SmartBrief on 10/29/2009
More from SmartBrief:
BioSante to use merger earnings for LibiGel clinical trials
Monday, August 10, 2009
Get stories like these delivered daily for FREE:
|
BIO SmartBrief
Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more |
|